208 related articles for article (PubMed ID: 12720024)
1. The medical management of primary open-angle glaucoma in the elderly patient.
Schoevaerdts D; Levecq L; Vanpee D; Swine C
Z Gerontol Geriatr; 2003 Apr; 36(2):121-3. PubMed ID: 12720024
[TBL] [Abstract][Full Text] [Related]
2. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
3. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
[TBL] [Abstract][Full Text] [Related]
4. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
[TBL] [Abstract][Full Text] [Related]
5. Open-angle glaucoma.
Distelhorst JS; Hughes GM
Am Fam Physician; 2003 May; 67(9):1937-44. PubMed ID: 12751655
[TBL] [Abstract][Full Text] [Related]
6. Modern alchemy: fixed combinations of glaucoma drugs.
Katz LJ
Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653
[No Abstract] [Full Text] [Related]
7. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
[TBL] [Abstract][Full Text] [Related]
8. The influence of topical diclofenac sodium on the ocular hypotensive effect of latanoprost in glaucoma patients.
Sorkhabi R; Alipanahi R; Eftakhari-Milani A; Ghojazadeh L
J Glaucoma; 2011; 20(4):240-3. PubMed ID: 20577116
[TBL] [Abstract][Full Text] [Related]
9. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey.
Ramakrishnan R; Nirmalan PK; Krishnadas R; Thulasiraj RD; Tielsch JM; Katz J; Friedman DS; Robin AL
Ophthalmology; 2003 Aug; 110(8):1484-90. PubMed ID: 12917161
[TBL] [Abstract][Full Text] [Related]
10. Glaucoma case report: a nutritional response.
Veach JE
Optometry; 2003 Dec; 74(12):775-81. PubMed ID: 14677729
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the biomechanical properties of the cornea in patients with normotensive and primary open-angle glaucoma].
Avetisov SE; Bubnova IA; Antonov AA
Vestn Oftalmol; 2008; 124(5):14-6. PubMed ID: 19062550
[TBL] [Abstract][Full Text] [Related]
13. Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss.
Hennessy AL; Katz J; Covert D; Protzko C; Robin AL
Ophthalmology; 2010 Dec; 117(12):2345-52. PubMed ID: 20580092
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
Quigley HA; Friedman DS; Hahn SR
Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498
[TBL] [Abstract][Full Text] [Related]
15. Real-life experience study of the safety and efficacy of travoprost 0.004% / timoptol 0.50% fixed combination ophthalmic solution in intraocular pressure control.
Olali C; Malietzis G; Ahmed S; Samaila E; Gupta M
Niger J Clin Pract; 2011; 14(1):29-33. PubMed ID: 21493988
[TBL] [Abstract][Full Text] [Related]
16. Bilateral ocular hypertension with rapidly progressive optic neuropathy in a teen.
Hua LV; Byrne E; Yudcovitch L
Optom Vis Sci; 2009 Sep; 86(9):E1117-26. PubMed ID: 19661835
[TBL] [Abstract][Full Text] [Related]
17. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
Egorov AE
Vestn Oftalmol; 1996; 112(2):3-4. PubMed ID: 9045485
[TBL] [Abstract][Full Text] [Related]
18. [Eye-pressure tonometry in prevention of glaucoma].
Ulrich WD; Ulrich C; Petzel C; Nenning N; Barth T
Ophthalmologe; 1993 Dec; 90(6):557-62. PubMed ID: 8124012
[TBL] [Abstract][Full Text] [Related]
19. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
